Vigabatrin (vigabatrin) price in Türkiye

Vigabatrin (Vigabatrin) is a drug used to treat epilepsy and is a member of the anti-epileptic drugs. It was first discovered by the Japanese pharmaceutical company Yangzijiang Pharmaceutical in 1977 and was first launched in Europe in 1989. Vigabatrin (vigabatrin)'s main mechanism of action is to increase the concentration of γ-aminobutyric acid (GABA), thereby inhibiting the excitability of neurons and reducing the occurrence of epileptic seizures.

Vigabatrin (vigabatrin) has now been launched in the domestic market and has been included in the medical insurance system. Patients can purchase it directly in China. However, it is expensive. For example, a package of 500mg*30 bags is priced at about 2,000 yuan. For more specific prices and medical insurance reimbursement details, please consult your local hospital pharmacy.

Since the export of Turkish medicines is currently prohibited according to local government regulations, all Turkish medicines are unavailable for purchase. The cost-effective original drugs mainly come from Hong Kong, China. Among them, drugs with specifications of 500mg*100 bags only cost more than 1,000 yuan, and their efficacy is the same as the domestic Vigabatrin (vigabatrin).

GABA is an important neurotransmitter in the central nervous system and has inhibitory effects. Vigabatrin (vigabatrin)increases GABA concentration in the synaptic cleft by inhibiting the activity of GABA aminotransferase. This allows GABA to bind more effectively to GABA receptors on neurons, producing a stronger inhibitory effect, thereby reducing neuronal excitability and helping to control epileptic seizures.

Vigabatrin (vigabatrin) is mainly used to treat partial epilepsy, a type of epilepsy that is limited to one part of the brain and may present with symptoms such as muscle twitching, loss of consciousness, or abnormal sensations. In addition, Vigabatrin (vigabatrin) is also used as an adjunctive treatment for epileptic syndromes such as infantile spasms, as well as other types of epilepsy such as complex partial epilepsy and conditions with frequent seizures.

However, it should be noted that long-term use ofvigabatrin (vigabatrin)may lead to optic neuropathy, especiallyvigabatrin (vigabatrin)related visual field defects, which may affect the patient's vision and even lead to blindness. Therefore, when using Vigabatrin (vigabatrin) , doctors usually recommend that patients receive regular eye exams and vision monitoring, as well as talk to their doctor about any possible vision problems.